Supreme Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-11-2024
- Paid Up Capital ₹ 1.00 M
as on 02-11-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
as on 02-11-2024
- Satisfied Charges ₹ 2.75 Cr
as on 02-11-2024
- Revenue %
(FY 2023)
- Net Worth 19.04%
(FY 2023)
- Total Assets 566.15%
(FY 2023)
About Supreme Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 Cr. The company has closed loans amounting to ₹2.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Asha Sanghvi, Kantilal Sanghvi, and Harshil Sanghvi serve as directors at the Company.
- CIN/LLPIN
U24298GJ2021PTC124921
- Company No.
124921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Supreme Pharmachem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshil Sanghvi  | Director | 16-Aug-2021 | Current |
| Asha Sanghvi | Director | 16-Aug-2021 | Current |
| Kantilal Sanghvi | Director | 16-Aug-2021 | Current |
Financial Performance of Supreme Pharmachem.
Supreme Pharmachem Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 19.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Supreme Pharmachem?
Unlock access to Supreme Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shalibhadrachemicals Pvt LtdActive 43 years 10 monthsAsha Sanghvi, Kantilal Sanghvi and 1 more are mutual person
Shalin Intermediates Private LimitedActive 35 years 1 monthAsha Sanghvi, Kantilal Sanghvi and 1 more are mutual person
- Siddhachal Tradelink Private LimitedActive 32 years 7 months
Asha Sanghvi and Kantilal Sanghvi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Oct 2023 | ₹1.50 Cr | Open |
Others Creation Date: 31 Oct 2023 | ₹2.00 Cr | Open |
Others Creation Date: 27 Sep 2022 | ₹2.75 Cr | Satisfied |
How Many Employees Work at Supreme Pharmachem?
Supreme Pharmachem has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supreme Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreme Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
